Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Clin Infect Dis ; 32(11): 1554-61, 2001 Jun 01.
Artigo em Inglês | MEDLINE | ID: mdl-11340526

RESUMO

Azole-resistant thrush has emerged as a problem in people who are infected with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS), especially those who have low CD4 cell counts who have had a previous relapse of oral candidiasis, and in those who require long-term suppressive antifungal therapy. Because of the development of a standardized methodology for antifungal susceptibility testing and interpretive criteria for resistance testing, studies of the clinical predictive value of in vitro results are possible. In this study, 61% of organisms isolated from patients who were receiving azole therapy and who had clinically resistant thrush had minimal inhibitory concentration values that would classify the isolate as "resistant" or "susceptible dose dependent." In contrast, 86% of isolates from patients with thrush that was clinically responsive to an azole were classified in vitro as "susceptible" or "susceptible dose dependent." No resistant isolates were detected in samples obtained from asymptomatic control patients who were not exposed to azole drugs. Serum levels of azole and CD4 cell counts were also important parameters with regard to prediction of response. We conclude that in vivo and in vitro correlations compare favorably to studies of susceptibility testing in bacteria.


Assuntos
Infecções Oportunistas Relacionadas com a AIDS/fisiopatologia , Antifúngicos/uso terapêutico , Candidíase/fisiopatologia , Fluconazol/uso terapêutico , HIV-1 , Cetoconazol/uso terapêutico , Doenças Faríngeas/fisiopatologia , Infecções Oportunistas Relacionadas com a AIDS/sangue , Infecções Oportunistas Relacionadas com a AIDS/tratamento farmacológico , Infecções Oportunistas Relacionadas com a AIDS/imunologia , Adolescente , Adulto , Antifúngicos/sangue , Antifúngicos/farmacologia , Candidíase/sangue , Candidíase/tratamento farmacológico , Candidíase/imunologia , Criança , Resistência Microbiana a Medicamentos , Feminino , Fluconazol/sangue , Fluconazol/farmacologia , Humanos , Tolerância Imunológica , Itraconazol/farmacologia , Itraconazol/uso terapêutico , Cetoconazol/sangue , Cetoconazol/farmacologia , Masculino , Testes de Sensibilidade Microbiana , Orofaringe , Doenças Faríngeas/sangue , Doenças Faríngeas/tratamento farmacológico , Doenças Faríngeas/imunologia
2.
Nihon Jibiinkoka Gakkai Kaiho ; 98(7): 1086-91, 1995 Jul.
Artigo em Japonês | MEDLINE | ID: mdl-7562228

RESUMO

We evaluated the relationship between birch pollen allergy and oral and pharyngeal hypersensitivities to certain fruits. 1. Of 171 birch pollen CAP positive (score > or = 2) patients, twenty two (13%) were revealed to be hypersensitive to apples, eleven (6%) to be hypersensitive to peaches, both rates being higher than those found in patients with other CAP positive reactions (orchard grass pollen CAP, mugwort pollen CAP or Dermatophagoides pteronyssius CAP positive). 2. Among the birch pollen CAP positive patients, the higher the CAP score for birch pollen, the higher the prevalences of hypersensitivity to apples and peaches were found to be. 3. Of 171 birch pollen CAP positive patients, six (3.5%) were revealed to be hypersensitive to kiwi fruit. Of 253 patients with other CAP positive reactions, three (1%) were revealed to be hypersensitive to kiwi fruit.


Assuntos
Frutas/imunologia , Hipersensibilidade/imunologia , Doenças da Boca/imunologia , Doenças Faríngeas/imunologia , Pólen/imunologia , Adolescente , Adulto , Idoso , Criança , Pré-Escolar , Feminino , Hipersensibilidade Alimentar/imunologia , Humanos , Imunoglobulina E/análise , Lactente , Masculino , Pessoa de Meia-Idade , Árvores
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA